Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.95 USD | -28.35% | -4.79% | +21.37% |
15/04 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
15/04 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |